Amelioration of aluminium chloride (AlCl3) induced neurotoxicity by combination of rivastigmine and memantine with artesunate in Albino Wistar rats

S. E. Praveenkumar, Kurady Laxminarayana Bairy, Veena Nayak, Shiva Kumar Reddy, Amruth Kiran, Abhijna Ballal

Research output: Contribution to journalArticle

Abstract

Alzheimer’s disease (AD) is an age-related progressive disorder characterized by neurodegeneration and accumulation of abnormal proteins.Artesunate, an anti-malarial drug has recently been shown to have anti-inflammatory, antiviral, angiogenic and other pleiotropic effects. It has also improved cognitive decline induced by hepatic coma which is suggestive of its role in learning and memory. In view of this, the current study was planned to assess the effect of the combination of artesunate with rivastigmine and memantine in aluminium chloride induced neurotoxicity.The study was conducted on 24 male adult albino wistar rats which were divided into four groups (n=6). Group - I to IV received saline, aluminium chloride (AlCl3), AlCl3 + artesunate +rivastigmine, AlCl3 + artesunate + memantine for 60 days respectively. After the 60th day of treatment, all animals were subjected to a passive avoidance task. All the animals were then sacrificed to study the histopathological changes in the hippocampus. Artesunate in combination with rivastigmine and memantine showed significant improvement in memory impairment and reduced neuronal death. Neuronal viability was more prominent in combination treatments as shown by histopathological results. Artesunate in combination with rivastigmine and memantine could be useful in AD. Artesunate can be used as an adjuvant therapy because artesunate combined with standard drugs produced significant neuroprotective effect.

Original languageEnglish
Pages (from-to)703-711
Number of pages9
JournalBiomedical and Pharmacology Journal
Volume12
Issue number2
DOIs
Publication statusPublished - 01-01-2019

Fingerprint

Rivastigmine
Memantine
Wistar Rats
Alzheimer Disease
Hepatic Encephalopathy
artesunate
aluminum chloride
Antimalarials
Neuroprotective Agents
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Praveenkumar, S. E. ; Bairy, Kurady Laxminarayana ; Nayak, Veena ; Reddy, Shiva Kumar ; Kiran, Amruth ; Ballal, Abhijna. / Amelioration of aluminium chloride (AlCl3) induced neurotoxicity by combination of rivastigmine and memantine with artesunate in Albino Wistar rats. In: Biomedical and Pharmacology Journal. 2019 ; Vol. 12, No. 2. pp. 703-711.
@article{789b8355ae934aadb1d52f26dfe9c99e,
title = "Amelioration of aluminium chloride (AlCl3) induced neurotoxicity by combination of rivastigmine and memantine with artesunate in Albino Wistar rats",
abstract = "Alzheimer’s disease (AD) is an age-related progressive disorder characterized by neurodegeneration and accumulation of abnormal proteins.Artesunate, an anti-malarial drug has recently been shown to have anti-inflammatory, antiviral, angiogenic and other pleiotropic effects. It has also improved cognitive decline induced by hepatic coma which is suggestive of its role in learning and memory. In view of this, the current study was planned to assess the effect of the combination of artesunate with rivastigmine and memantine in aluminium chloride induced neurotoxicity.The study was conducted on 24 male adult albino wistar rats which were divided into four groups (n=6). Group - I to IV received saline, aluminium chloride (AlCl3), AlCl3 + artesunate +rivastigmine, AlCl3 + artesunate + memantine for 60 days respectively. After the 60th day of treatment, all animals were subjected to a passive avoidance task. All the animals were then sacrificed to study the histopathological changes in the hippocampus. Artesunate in combination with rivastigmine and memantine showed significant improvement in memory impairment and reduced neuronal death. Neuronal viability was more prominent in combination treatments as shown by histopathological results. Artesunate in combination with rivastigmine and memantine could be useful in AD. Artesunate can be used as an adjuvant therapy because artesunate combined with standard drugs produced significant neuroprotective effect.",
author = "Praveenkumar, {S. E.} and Bairy, {Kurady Laxminarayana} and Veena Nayak and Reddy, {Shiva Kumar} and Amruth Kiran and Abhijna Ballal",
year = "2019",
month = "1",
day = "1",
doi = "10.13005/bpj/1692",
language = "English",
volume = "12",
pages = "703--711",
journal = "Biomedical and Pharmacology Journal",
issn = "0974-6242",
publisher = "Oriental Scientific Publishing Company",
number = "2",

}

Amelioration of aluminium chloride (AlCl3) induced neurotoxicity by combination of rivastigmine and memantine with artesunate in Albino Wistar rats. / Praveenkumar, S. E.; Bairy, Kurady Laxminarayana; Nayak, Veena; Reddy, Shiva Kumar; Kiran, Amruth; Ballal, Abhijna.

In: Biomedical and Pharmacology Journal, Vol. 12, No. 2, 01.01.2019, p. 703-711.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Amelioration of aluminium chloride (AlCl3) induced neurotoxicity by combination of rivastigmine and memantine with artesunate in Albino Wistar rats

AU - Praveenkumar, S. E.

AU - Bairy, Kurady Laxminarayana

AU - Nayak, Veena

AU - Reddy, Shiva Kumar

AU - Kiran, Amruth

AU - Ballal, Abhijna

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Alzheimer’s disease (AD) is an age-related progressive disorder characterized by neurodegeneration and accumulation of abnormal proteins.Artesunate, an anti-malarial drug has recently been shown to have anti-inflammatory, antiviral, angiogenic and other pleiotropic effects. It has also improved cognitive decline induced by hepatic coma which is suggestive of its role in learning and memory. In view of this, the current study was planned to assess the effect of the combination of artesunate with rivastigmine and memantine in aluminium chloride induced neurotoxicity.The study was conducted on 24 male adult albino wistar rats which were divided into four groups (n=6). Group - I to IV received saline, aluminium chloride (AlCl3), AlCl3 + artesunate +rivastigmine, AlCl3 + artesunate + memantine for 60 days respectively. After the 60th day of treatment, all animals were subjected to a passive avoidance task. All the animals were then sacrificed to study the histopathological changes in the hippocampus. Artesunate in combination with rivastigmine and memantine showed significant improvement in memory impairment and reduced neuronal death. Neuronal viability was more prominent in combination treatments as shown by histopathological results. Artesunate in combination with rivastigmine and memantine could be useful in AD. Artesunate can be used as an adjuvant therapy because artesunate combined with standard drugs produced significant neuroprotective effect.

AB - Alzheimer’s disease (AD) is an age-related progressive disorder characterized by neurodegeneration and accumulation of abnormal proteins.Artesunate, an anti-malarial drug has recently been shown to have anti-inflammatory, antiviral, angiogenic and other pleiotropic effects. It has also improved cognitive decline induced by hepatic coma which is suggestive of its role in learning and memory. In view of this, the current study was planned to assess the effect of the combination of artesunate with rivastigmine and memantine in aluminium chloride induced neurotoxicity.The study was conducted on 24 male adult albino wistar rats which were divided into four groups (n=6). Group - I to IV received saline, aluminium chloride (AlCl3), AlCl3 + artesunate +rivastigmine, AlCl3 + artesunate + memantine for 60 days respectively. After the 60th day of treatment, all animals were subjected to a passive avoidance task. All the animals were then sacrificed to study the histopathological changes in the hippocampus. Artesunate in combination with rivastigmine and memantine showed significant improvement in memory impairment and reduced neuronal death. Neuronal viability was more prominent in combination treatments as shown by histopathological results. Artesunate in combination with rivastigmine and memantine could be useful in AD. Artesunate can be used as an adjuvant therapy because artesunate combined with standard drugs produced significant neuroprotective effect.

UR - http://www.scopus.com/inward/record.url?scp=85069619197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069619197&partnerID=8YFLogxK

U2 - 10.13005/bpj/1692

DO - 10.13005/bpj/1692

M3 - Article

VL - 12

SP - 703

EP - 711

JO - Biomedical and Pharmacology Journal

JF - Biomedical and Pharmacology Journal

SN - 0974-6242

IS - 2

ER -